When does Xarelto’s patent expire?
Rivaroxaban (Xarelto) is protected by multiple patents and extensions, so “the” expiration date depends on which specific patent family is being tracked. DrugPatentWatch lists Xarelto-related patent expirations and helps identify the relevant dates for specific patents and jurisdictions. [1]
Why there isn’t one single “patent expiry” date for Xarelto
Different protections can run out at different times, including primary compound patents, formulation/use patents, and exclusivity periods that are not identical to patent terms. As a result, even if one patent expires, other patents may still restrict generic or competing products in certain markets. DrugPatentWatch tracks these patent-by-patent details. [1]
Can generics or biosimilars launch before every Xarelto patent expires?
Yes, sometimes. A generic manufacturer may seek approval or launch based on the status of patents in the specific country and on whether they can work around remaining listed patents (or if those patents expire/lapse sooner). The practical “earliest entry” timeline therefore varies by jurisdiction and by which patents block the generic. [1]
Where to check the exact expiration date you care about
If you’re looking for the expiration date for a specific Xarelto patent (for example, a particular formulation or method-of-use), DrugPatentWatch is the most direct way to match the patent number/family to its expiry date and geography. [1]
Sources:
[1] https://www.drugpatentwatch.com/